Ensuring drug safety is a continuous process that extends far beyond a medication’s initial FDA approval. Pharmacists must be skilled at locating, critically appraising, and applying drug safety literature to make informed clinical decisions that protect their patients. This skill is a core component of Evidence-Based Practice, as taught in the PHA5244 course, and is … Read more
Reading a research study is not enough; a pharmacist must be able to critically appraise it to determine its trustworthiness and applicability to patient care. Critiquing pharmacoepidemiology studies, a core skill taught in the Principles of Evidence-Based Practice course and applied in Journal Clubs, involves a systematic evaluation of the study’s methods to identify potential … Read more
Machine Learning (ML), a powerful subset of Artificial Intelligence, enables computer systems to learn from vast amounts of data to make predictions and improve processes. Its role in pharmacy practice is rapidly expanding, with applications ranging from personalizing medication regimens to predicting adverse drug events and optimizing pharmacy operations. This quiz explores the fundamental concepts … Read more
Term “Artificial Intelligence” is not explicitly listed as a module in your syllabus, it represents the next evolution of the “Health Information and Informatics” and “Automated Systems” topics that are covered in your curriculum “. Artificial Intelligence (AI) is a transformative force in healthcare with significant potential to enhance pharmacy practice. This quiz will explore … Read more
Comparative Effectiveness Research (CER) is designed to answer a crucial clinical question: “Which treatment works best, for whom, and under what circumstances?” Unlike traditional placebo-controlled trials that focus on efficacy, CER directly compares active treatment options to inform real-world medical decisions for patients, clinicians, and policymakers. Understanding the principles of CER, a key topic in … Read more
In any pharmacoepidemiologic study, a clear and accurate definition of the “exposure”—typically a medication—is just as critical as the outcome being measured. How researchers ascertain drug exposure from sources like claims data or electronic health records can introduce significant bias and affect a study’s validity. The ability to critically appraise exposure measurement is a key … Read more
The choice of an endpoint is one of the most critical decisions in designing a clinical or pharmacoepidemiologic study, as it determines what is being measured and how the results will be interpreted. Pharmacists must be adept at scrutinizing study endpoints to differentiate between a change in a lab value (a surrogate endpoint) and a … Read more
The value of any pharmacoepidemiology study hinges on the outcomes it measures. As a pharmacist, understanding and critically evaluating these outcomes is an essential skill for evidence-based practice. As taught in the Principles of Evidence-Based Practice course, it is crucial to differentiate between a direct clinical outcome, like preventing a stroke, and a surrogate outcome, … Read more
Pharmacoepidemiology is the essential science that evaluates the real-world performance of medications after they reach the market. Its primary role is to bridge the gap between the controlled environment of clinical trials and the complex reality of patient care, focusing on drug safety, effectiveness, and utilization in large populations. Understanding this role, a key component … Read more
The U.S. Food and Drug Administration (FDA) is the primary federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of our nation’s drug supply. Understanding FDA drug policy, a cornerstone of the Principles of Pharmacy Law and Ethics course, is essential for every pharmacist to practice legally and ethically. This … Read more
